Medicine Overview of Invog M Tablet
Nausea, Altered taste, Loss of appetite, Flatulence, Stomach pain, Diarrhoea, Skin rash.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Invog M 500 mg/0.3 mg Tablet is to be taken with food.
Invog M 500 mg/0.3 mg Tablet may cause stomach upset if taken on empty stomach.
Invog M 500 mg/0.3 mg Tablet is a combination of two antidiabetic medicines: Metformin and voglibose. Metformin lowers the production and absorption of sugar in your body and allows better use of existing insulin. Voglibose inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. This prevents blood glucose from rising very high after meals.
In Depth Information on Invog M Tablet
Invog M Tablet related warnings
Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
Invog M 500 mg/0.3 mg Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Invog M 500 mg/0.3 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Invog M 500 mg/0.3 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Invog M 500 mg/0.3 mg Tablet may be needed. Please consult your doctor.
Use of Invog M 500 mg/0.3 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Invog M 500 mg/0.3 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Invog M 500 mg/0.3 mg Tablet may be needed. Please consult your doctor.
Invog M 500 mg/0.3 mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Invog M 500 mg/0.3 mg Tablet
Patients taking Invog M 500 mg/0.3 mg Tablet What are you using Invog M Tablet for?
Survey Participants: 1
“The following are the results of on-going survey on 1mg.com for Invog M 500 mg/0.3 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Invog M 500 mg/0.3 mg Tablet: HPC, RSA, ENP, SGH, UMP, BHP, MAK, JVN, QTM, SBA, RSS, RHW, HGI, EVP, HTS, IAD, OHM, RPI, SLN, IPL, ZEL, WSI, MMS, STA, NVL, MPC, CLT, FGH, BIO, JIV, BMJ, JSL, ZVP, VRS, QLF, DPL, SSA, SHD, ANT, ATL, PWN, SBL, DGN, SRG, PMA, MLC, GBL, KMC, HZF, AGT, PPR, DVH, PTI, AAY, SGC, MDO, SJP, BLE, LCC, PLT, MSD, OWP, GNC, HMP, RDR, HBV, SDM, PNT, 9T9, MDH, HNP, BAP, JVO, SHP, AYM, OLT, DLP, NSL, AMR, AAR, SWA, HEX, HSP, HIP, GTK, HAT, NDP, RUS, RJH, SVH, TFP, SWP, PRN, P2P, TNH, BHM, EQN, NTB, MAX, LHA, RDH, ABP, AYU, DFP, BBS, KHH, BSN, NVY, GPP, PEN, BDN, VDH, SYN, ADT, TOM, ESY, GPT, RWP, VNS, RPP, TRP, NNH, GTC, RHL, ARD, DHR, USF, ATP, OIP, BAL, SHC, GHR, INC, PVP, SCH, WHL, KHC, MAM, SAF, EMB, THP, DYG, RKS, NXG, DPP, BTM